AstraZeneca will have 200 million Covid-19 vaccine doses by this year end 

 
AstraZeneca will have 200 million doses of its candidate vaccine developed by the University of Oxford by the end of 2020, with 700 million doses ready globally by the end of the first quarter of 2021, operations executive Pam Cheng said on Monday.